This monthly feature presents questions from clinical trial professionals with answers from experts. In this issue, we feature insights from WCG IRB Chair Erin Brower on the differences between eConsent and eSignatures.
Read More
In an effort to encourage others to be clear about the full costs of their clinical trials, the international nonprofit Doctors Without Borders will openly share the detailed expenses for a tuberculosis (TB) trial using a new transparency tool it created.
Read More
This week’s Pipeline features a phase 3 trial approval for Alzheimer’s disease, a phase 2 trial start for newly diagnosed glioblastoma multiforme and an FDA approval for a spinal cord stimulator that treats chronic pain.
Read More